![Sonia Gulati](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sonia Gulati is currently the Chief Executive Officer & Director at Leukovet.
She is also a Director at TigaTx, Inc. and an Investment Review Committee Member at Accelerate Long Island (Venture Capital).
Previously, she was a Director at Actinobac Biomed, Inc., Pinpoint Therapeutics, Inc., and 1200 Pharma LLC.
She was also an Assistant Director at New York Ventures.
Dr. Gulati received her undergraduate degree from Barnard College and her doctorate from Columbia University School of the Arts in 2011.
| Sociétés | Poste | Début |
|---|---|---|
Leukovet
 Leukovet Pharmaceuticals: MajorHealth Technology Develops peptide-based cancer therapeutics for treatment of canine lymphoma, leukemia and other immunological diseases | Directeur Général | - |
Accelerate Long Island (Venture Capital)
 Accelerate Long Island (Venture Capital) Investment ManagersFinance Accelerate Long Island (Venture Capital) invests in companies located in the United States. The firm targets companies operating across a broad of sectors and industries. It provides financing for seed capital requirements. | Private Equity Investor | - |
TigaTx, Inc.
 TigaTx, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops engineered immunoglobulin to create isotype cancer antibody | Directeur/Membre du Conseil | 01/09/2009 |
| Sociétés | Poste | Fin |
|---|---|---|
Actinobac Biomed, Inc.
 Actinobac Biomed, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical technologies | Directeur/Membre du Conseil | 30/09/2021 |
1200 Pharma LLC
 1200 Pharma LLC Pharmaceuticals: MajorHealth Technology Provides pre-clinical drug discovery and clinical approval services | Directeur/Membre du Conseil | 31/08/2021 |
Pinpoint Therapeutics, Inc.
 Pinpoint Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures therapeutics for cancer treatments | Directeur/Membre du Conseil | 31/08/2021 |
New York Ventures
 New York Ventures Investment ManagersFinance New York State Innovation invests in companies located in the United States. The firm focuses on a broad range of sectors. It participates in seed and early-stage transactions. | Private Equity Investor | 31/12/2018 |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 9 |
|---|---|
Barnard College
 Barnard College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Actinobac Biomed, Inc.
Actinobac Biomed, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical technologies | Health Technology |
New York Ventures
New York Ventures Investment ManagersFinance New York State Innovation invests in companies located in the United States. The firm focuses on a broad range of sectors. It participates in seed and early-stage transactions. | Finance |
Columbia University School of the Arts
 Columbia University School of the Arts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
1200 Pharma LLC
1200 Pharma LLC Pharmaceuticals: MajorHealth Technology Provides pre-clinical drug discovery and clinical approval services | Health Technology |
Accelerate Long Island (Venture Capital)
Accelerate Long Island (Venture Capital) Investment ManagersFinance Accelerate Long Island (Venture Capital) invests in companies located in the United States. The firm targets companies operating across a broad of sectors and industries. It provides financing for seed capital requirements. | Finance |
Pinpoint Therapeutics, Inc.
Pinpoint Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures therapeutics for cancer treatments | Health Technology |
Leukovet
Leukovet Pharmaceuticals: MajorHealth Technology Develops peptide-based cancer therapeutics for treatment of canine lymphoma, leukemia and other immunological diseases | Health Technology |
TigaTx, Inc.
TigaTx, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops engineered immunoglobulin to create isotype cancer antibody | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
Choisissez Zonebourse 
